Newswise — The NY Times reported Tuesday about how the Food and Drug Administration is weighing a controversial fertility procedure that involves combining the genetic material of three people to make a baby free of certain defects, a therapy that critics say is an ethical minefield and could lead to the creation of designer babies.

Dr. Tamer Yalcinkaya, Assisted Reproductive Technology Director at Wake Forest Baptist Medical Center, has been active in the fields of reproductive technology and endocrinology-infertility for 23 years. He has extensive clinical experience in infertility, reproductive endocrinology, and assisted reproductive technology, and fibroids and can provide comment on this topic